Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0

作者：

Lord H. ^{[1
,2
]}

机构：

[1] University of Montréal, Montréal, Que.

[2] Maisonneuve Rosemont, University of Montréal, Montréal, Que. HIT 2M4

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Sirolimus; Risedronate; Mycophenolate Mofetil; Graft Function; Darbepoetin Alfa;

D O I：

10.2165/00003495-200666002-00004

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

下载

页码：11 / 13

页数：2

共 50 条

[1] Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Lord, Helene
DRUGS, 2006, 66 : 11 - 13
[2] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer, Murat
DRUGS, 2006, 66 : 9 - 10
[3] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer M.
Drugs, 2006, 66 (Suppl 2) : 9 - 10
[4] Complete resolution of severe diarrhoea after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient at high immunological risk
Breidenbach, Thomas
Spangenberg, Marcus
Nagel, Eckhard
DRUGS, 2006, 66 : 25 - 27
[5] Complete Resolution of Severe Diarrhoea after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient at High Immunological Risk
Thomas Breidenbach
Marcus Spangenberg
Eckhard Nagel
Drugs, 2006, 66 (Suppl 2) : 25 - 27
[6] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich, Pierre-Sinion
Deconinck, Eric
Cahn, Jean-Yves
Plouvier, Emmanuel
DRUGS, 2006, 66 : 33 - 35
[7] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich P.-S.
Deconinck E.
Cahn J.-Y.
Plouvier E.
Drugs, 2006, 66 (Suppl 2) : 33 - 35
[8] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease
Kuhnowski F.
Terriou L.
Magro L.
Jouet J.-P.
Yakoub-Agha I.
Drugs, 2006, 66 (Suppl 2) : 29 - 31
[9] Gastrointestinal Quality of Life Improvement of Renal Transplant Recipients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Drugs or Agents: Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium
Ortega, Francisco
Sanchez-Fructuoso, Ana
Maria Cruzado, Jose
Carlos Gomez-Alamillo, Juan
Alarcon, Antonio
Pallardo, Lluis
Maria Morales, Jose
Oliver, Juan
Guinea, Guillermo
TRANSPLANTATION, 2011, 92 (04) : 426 - 432
[10] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease
Kuhnowski, Frederique
Terriou, Louis
Magro, Leonardo
Jouet, Jean-Pierre
Yakoub-Agha, Ibrahim
DRUGS, 2006, 66 : 29 - 31

← 1 2 3 4 5 →